Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
lebrikizumab interleukin-13 biotech Clinical trial target TTD , drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Eczema[MeSHID:D004485]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Hamman-Rich syndrome[MeSHID:D011658]
Dermatitis
Atopic[MeSHID:D003876]
Idiopathic Pulmonary Fibrosis[MeSHID:D054990]
Asthma[MeSHID:D001249]		 15.91 investigational,phase 3 inhibitor
lebrikizumab interleukin-13 biotech Clinical trial target TTD , drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Eczema[MeSHID:D004485]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Hamman-Rich syndrome[MeSHID:D011658]
Dermatitis
Atopic[MeSHID:D003876]
Idiopathic Pulmonary Fibrosis[MeSHID:D054990]
Asthma[MeSHID:D001249]		 15.91 investigational,phase 3 unknown
lebrikizumab il13 protein biotech NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Eczema[MeSHID:D004485]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Hamman-Rich syndrome[MeSHID:D011658]
Dermatitis
Atopic[MeSHID:D003876]
Idiopathic Pulmonary Fibrosis[MeSHID:D054990]
Asthma[MeSHID:D001249]		 15.91 investigational unknown
lebrikizumab il13 protein biotech NA drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Eczema[MeSHID:D004485]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Hamman-Rich syndrome[MeSHID:D011658]
Dermatitis
Atopic[MeSHID:D003876]
Idiopathic Pulmonary Fibrosis[MeSHID:D054990]
Asthma[MeSHID:D001249]		 15.91 investigational inhibitor
click here to return to the previous page